David Loew

Executive Vice President – Sanofi Pasteur,

Currently, Executive Vice-President, Sanofi Pasteur, the vaccines Global Business Unit of Sanofi, and Member of the Executive Committee, Sanofi. Sanofi Pasteur manufacturers and markets a diverse portfolio of vaccines for children, adolescents and adults, including influenza, meningitis, travel and endemic diseases. Sanofi Pasteur is a world leader in influenza and paediatric vaccines, and the first worldwide supplier of polio injectable vaccine. The vaccines help protect as many as half a billion lives each year against life-threatening diseases. Previously, Head of Global Commercial Operations, Sanofi Pasteur; joined Sanofi in 2013 as Senior Vice-President, Commercial Operations, Europe, responsible for the pharmaceutical business across 38 countries. Before working for Sanofi, 20 years with Roche, latterly as Region Head, Eastern Europe, Middle East and Africa and Global Chief Marketing Officer for the pharmaceutical division. Started career in the US at Coopers & Lybrand and Hewlett Packard. Master’s in Economics and Business Administration, University of St. Gallen (HSG), Switzerland. Member, Vaccine CEO Steering Committee, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). Former Member of the Board, GAVI.

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum